Heike Püschel

A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

Cyrill A. Rentsch, George N. Thalmann, Ilaria Lucca et al. · European Urology Oncology · 2022 · 38 citations

Medicine, Oncology, Urology +17

Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy

Cyrill A. Rentsch, Piet Bosshard, G. Mayor et al. · OncoImmunology · 2020 · 31 citations · Full text

Medicine, Immunology, Oncology +16

Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)

Ivana Bratić Hench, Richard Cathomas, Luigi Costa et al. · Cancers · 2019 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

Prospective Multicenter Validation of the Stockholm3 Test in a Central European Cohort

Anas Elyan, Karim Saba, August Sigle et al. · European Urology Focus · 2023 · 13 citations · Full text

Medicine, Pathology, Urology +17

Incidental prostate cancer prevalence at radical cystoprostatectomy—importance of the histopathological work-up

Christian Wetterauer, M Weibel, Joël Gsponer et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2014 · 12 citations

Medicine, Surgery, Urology +16